Trademark: 87717521
Word
SYNEOS HEALTH
Status
Registered
Status Code
700
Status Date
Tuesday, July 23, 2019
Serial Number
87717521
Registration Number
5814321
Registration Date
Tuesday, July 23, 2019
Mark Type
3000
Filing Date
Tuesday, December 12, 2017
Published for Opposition
Tuesday, January 8, 2019

Trademark Owner History
SYNEOS HEALTH, LLC - Original Registrant
INC Research, LLC - Owner At Publication

Classifications
41 Education in the field of pharmaceutical sales, namely, providing webinars, providing live workshops, providing on-line non-downloadable videos, providing on-line non-downloadable publications in the nature of articles and white papers, and providing podcasts; training services in the field of pharmaceutical sales; providing on-line non-downloadable newsletters and bulletins in the pharmaceutical, biotechnology and life sciences fields; educational services in the field of clinical trials, namely, providing on-line non-downloadable videos, webinars, live workshops, providing online non-downloadable publications in the nature of articles and white papers, and providing podcasts
35 Strategic business consulting, marketing and advertising, public relations communications strategy, information and data collection for business purposes, and business data analytics, namely, analyzing business data to understand and evaluate business performance, all of the aforementioned in the pharmaceutical, biotechnology and life sciences fields; sales promotion services; market analysis and research services; personnel recruitment and placement; recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of pharmaceuticals and devices; consulting in sales techniques and sales programs; sales volume tracking for others, all in the pharmaceutical, biotechnology and life sciences fields; business consulting in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; assisting pharmaceutical and biotechnology companies with applications for new drugs with governmental regulatory bodies; promoting the exchange of health information to promote patient adherence
44 Providing medical information to physicians, other health care professionals and for medical patients; providing health information regarding the medications and health care products of others, namely, product discontinuations, new formulations, bottle changes, and seasonal information through e-mail alerts and push notifications
42 Medical, scientific and data analysis research services for others, namely, conducting and analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; pharmaceutical drug development services, namely, developing clinical trial methodologies; consulting services in the area of pharmaceutical clinical testing; extended clinical research services for others, namely, computerized data management of clinical trials, biostatistical analysis, environmental consultancy, preclinical research and development evaluation, repairing flawed clinical trials and dossiers, strategic clinical research portfolio management, and biosurveillance monitoring; providing life science and scientific research information to physicians and other health care professionals, patients, and medical, pharmaceutical and biotechnology companies; providing regulatory compliant technical writing services in the field of medical research and clinical studies; consulting services in the field of contract clinical research and contract product development; Internet development, design and consulting services for others, namely, creating websites featuring blogs about medical and pharmaceutical information related to chronic illnesses and disease, creating an online community for patients and caregivers to communicate about healthcare, and design and development of interactive software for use in the communication and dissemination of medical and pharmaceutical information
The mark consists of the term "Syneos" with the term "Health" below 'Syneos". A broken infinity symbol is in a slanted position above the letter "s" in "Syneos".
Color is not claimed as a feature of the mark.
The wording "Syneos" has no meaning in a foreign language.
"HEALTH"

Trademark Events
Oct 4, 2023
Assignment Of Ownership Not Updated Automatically
Mar 15, 2023
Assignment Of Ownership Not Updated Automatically
Jul 23, 2019
Registered-Principal Register
Jun 15, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 14, 2019
Allowed Principal Register - Sou Accepted
May 18, 2019
Statement Of Use Processing Complete
May 6, 2019
Use Amendment Filed
May 18, 2019
Case Assigned To Intent To Use Paralegal
May 6, 2019
Teas Statement Of Use Received
Apr 24, 2019
Automatic Update Of Assignment Of Ownership
Apr 2, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 2, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 5, 2019
Noa E-Mailed - Sou Required From Applicant
Jan 8, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 8, 2019
Published For Opposition
Dec 19, 2018
Notification Of Notice Of Publication E-Mailed
Nov 15, 2018
Approved For Pub - Principal Register
Oct 5, 2018
Teas/Email Correspondence Entered
Oct 4, 2018
Correspondence Received In Law Office
Oct 4, 2018
Teas Response To Office Action Received
Jul 5, 2018
Notification Of Non-Final Action E-Mailed
Jul 5, 2018
Non-Final Action E-Mailed
Jul 5, 2018
Non-Final Action Written
Jun 14, 2018
Teas/Email Correspondence Entered
Jun 14, 2018
Correspondence Received In Law Office
Jun 14, 2018
Teas Response To Office Action Received
Mar 30, 2018
Notification Of Non-Final Action E-Mailed
Mar 30, 2018
Non-Final Action E-Mailed
Mar 30, 2018
Non-Final Action Written
Mar 22, 2018
Assigned To Examiner
Dec 22, 2017
Notice Of Design Search Code E-Mailed
Dec 21, 2017
New Application Office Supplied Data Entered
Dec 15, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24